Hospital playing key role in blindness research trials
- Credit: JPUH
Staff and patients at James Paget University Hospital have played an important role in tackling a condition which causes blindness.
The James Paget took part in the LumiThera Lightsite II clinical study, which is trialling a treatment for intermediate dry age-related macular degeneration.
Macular degeneration is the most common cause of blindness in people aged over 60 in the western world and, for the dry form of the disease, there is currently no effective proven treatment.
The trials saw patients given three rounds of photobiomodulation sessions every four months and the results demonstrated a significant improvement for those receiving the treatment.
Consultant Ophthalmologist Professor Ben Burton, who is James Paget’s clinical director of research and development, said: "Being able to prevent further vision loss and potentially slowing the progression of disease would be a huge benefit for patients.”
You may also want to watch:
The trials are entering a third stage in the United States.
- 1 Search continues for Beccles man missing for five days
- 2 Man admits crashing into five cars and a level crossing
- 3 Improving town's connectivity could 'attract more residents and visitors'
- 4 Man kicked and punched in head by group of attackers
- 5 Drivers facing long delays on A146 due to roadworks
- 6 Masks scrapped 'as early as next month' and over 35s jabs 'soon'
- 7 McDonald's branch to close for up to three months
- 8 New faces announced for town councils after election votes counted
- 9 Schools in ‘very difficult position’ over pupil classroom face mask changes
- 10 Teenager given big break with weekly show on coastal radio station